600587 新华医疗
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.0869.27410.2919.70511.969
总资产报酬率 ROA (%)1.0404.4454.5814.0704.804
投入资产回报率 ROIC (%)1.4326.1826.4125.6346.560

边际利润分析
销售毛利率 (%)23.78726.05626.48226.43924.251
营业利润率 (%)8.2457.9697.5616.3127.595
息税前利润/营业总收入 (%)8.4908.1317.5216.6018.244
净利润/营业总收入 (%)6.9876.9056.7575.6775.864

收益指标分析
经营活动净收益/利润总额(%)83.290100.077104.644104.08876.226
价值变动净收益/利润总额(%)6.1018.90112.6801.10624.143
营业外收支净额/利润总额(%)-0.148-0.359-2.488-1.691-0.300

偿债能力分析
流动比率 (X)1.3231.2941.2611.0691.026
速动比率 (X)0.8370.8300.7870.6310.643
资产负债率 (%)46.69248.58750.48355.34954.637
带息债务/全部投入资本 (%)28.40530.23332.31939.79739.145
股东权益/带息债务 (%)244.936224.087202.896146.619147.483
股东权益/负债合计 (%)108.826100.70892.98875.14877.452
利息保障倍数 (X)32.94942.65052.27816.72812.281

营运能力分析
应收账款周转天数 (天)74.48164.20661.08463.54662.257
存货周转天数 (天)171.037167.911161.024140.631116.483